U.S. Point of Care (PoC) Diagnostics Market Size Worth USD 18.83 Billion by 2034 | CAGR: 6.88%

The U.S. point-of-care (PoC) diagnostics market size is expected to reach USD 18.83 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Point of Care (PoC) diagnostics Market Share, Size, Trends, Industry Analysis Report: By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, and By End Use; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Point-of-Care (PoC) diagnostics are rapid diagnostics that provide testing and diagnosis as close to the patient as possible and with the timeliness to provide clinical decision support. The market is driven by the increased connectivity of decentralized testing, thereby decreasing reliance on centralized labs while also supporting immediate diagnosis of patients regardless of the location of health care services. These new testing solutions provide enhanced support for care delivery of new testing and diagnosis while enabling quick treatment and improved turnaround times. Improving outcomes allows for quicker intervention when necessary, contributing to the goal of providing accessible and appropriate healthcare to all patients. PoC diagnostics will expand the use case of decentralized diagnostic testing and shape the future healthcare environments.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-point-of-care-diagnostics-market/request-for-sample

The U.S. market growth is driven by the ongoing advances in this area of PoC diagnostics that relate to performance, connectivity, and usability. Innovations in the market, such as digitally connected devices, smaller portable medical devices, and refined molecular platforms, deliver better performance and more useful forms of testing. The more recent innovations improve healthcare workflows by allowing the user to extract and efficiently integrate results directly into the patient’s EHRs, improving clinical monitoring and increasing the efficiency of the care team. PoC diagnostics is well-positioned to provide reliable and real-time results, making it an important driver of better healthcare outcomes with these types of innovations being regularly introduced.

Top of FormU.S. Point-of-Care (PoC) diagnostics Market Report Highlights

• In terms of product, in 2024, the infectious diseases segment accounted for 36.91% revenue share in 2024 due to the increasing demand for accurate and rapid detection of diseases.
• Based on mode of prescription, the OTC segment is expected to witness growth at a CAGR of 1.8% during the forecast period driven by the increasing patient demand for monitoring and self-testing.
• In terms of end use, the clinics segment held 36.82% share of the market in 2024 owing to their role in delivering rapid diagnostic services to a wide patient base.
• A few global key market players include Abbott; Agilent Technologies, Inc.; BD; BIOMÉRIEUX; Danaher Corporation; Hologic, Inc.; Illumina, Inc.; Quest Diagnostics Incorporated; QuidelOrtho Corporation; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the market report on the basis of product, mode of prescription, and end use:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
  • HIV
  • Clostridium Difficile
  • HBV
  • Pneumonia or Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV)
  • HPV
  • Influenza/Flu
  • HCV
  • MRSA
  • TB and Drug-Resistant TB
  • HSV
  • Others
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

By Mode of Prescription (Revenue, USD Billion, 2020–2034)

• OTC
• Prescription-based

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Clinics
  • Physician Office
  • Pharmacy & Retail Clinics
  • Non-practice Clinics
  • Urgent Care Clinic
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory